The Netherlands Cancer Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
22 Pages - GLDATA58242
$250.00

Summary

The Netherlands Cancer Institute (NCI) is a research institute that conducts research on cancer and related disease. The institute offers scientific and clinical development and training services. It conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene regulation, immunology, psychosocial research and epidemiology among others. NCI provides education to postdoctoral fellows, Ph.D. students and technicians. The institute offers courses in the fields of biology, medicine, chemistry and basic medical statistics course. It operates facilities including bioanalytical laboratory of the pharmacy, biostatistics center, carcinogen laboratory, digital microscopy facility and flow cytometry facility. NCI is headquartered in Amsterdam, the Netherlands.

The Netherlands Cancer Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Netherlands Cancer Institute, Medical Devices Deals, 2010 to YTD 2016 9
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kite Pharma Enters into Option Agreement with Netherlands Cancer Institute to License T Cell Receptor Cancer Immunotherapy Product Candidates 11
Neon Therapeutics Enters into Research Agreement with Netherlands Cancer Institute 12
Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 13
Agendia Enters Into Collaboration With AstraZeneca And The Netherlands Cancer Institute 14
MUbio Products Enters Into Distribution Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital 16
Licensing Agreements 17
Forma Therapeutics Enters Into Licensing Agreement With Netherlands Cancer Institute 17
The Netherlands Cancer Institute - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Key Facts 1
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Netherlands Cancer Institute, Deals By Therapy Area, 2010 to YTD 2016 8
The Netherlands Cancer Institute, Medical Devices Deals, 2010 to YTD 2016 9
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Kite Pharma Enters into Option Agreement with Netherlands Cancer Institute to License T Cell Receptor Cancer Immunotherapy Product Candidates 11
Neon Therapeutics Enters into Research Agreement with Netherlands Cancer Institute 12
Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 13
Agendia Enters Into Collaboration With AstraZeneca And The Netherlands Cancer Institute 14
MUbio Products Enters Into Distribution Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital 16
Forma Therapeutics Enters Into Licensing Agreement With Netherlands Cancer Institute 17
The Netherlands Cancer Institute, Key Competitors 19
The Netherlands Cancer Institute, Key Employees 20
The Netherlands Cancer Institute, Subsidiaries 21

List of Figures
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
The Netherlands Cancer Institute, Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838